CTC, CELLSEARCH®

El recuento de CTC de CELLSEARCH® demuestra su utilidad en cáncer de mama metastásico HR+/ HER2-

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Menarini Silicon Biosystems United States of America Canada France Germany Spain United Kingdom Italy

View original content:https://www.prnewswire.com/news-releases/el-recuento-de-ctc-de-cellsearch-demuestra-su-utilidad-en-cancer-de-mama-metastasico-hrher2--302035046.html

en | boerse | 67967852 |